Open-label trial of riluzole in generalized anxiety disorder.
about
Review of the use of the glutamate antagonist riluzole in psychiatric disorders and a description of recent use in childhood obsessive-compulsive disorderGlutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatmentA New Outlook on Mental Illnesses: Glial Involvement Beyond the GlueChronic antidepressant treatment impairs the acquisition of fear extinction.Advances in the treatment of anxiety: targeting glutamate.Novel approaches in treatment of pediatric anxiety.A psychopharmacological treatment algorithm for generalised anxiety disorder (GAD)Polymorphisms in GRIK4, HTR2A, and FKBP5 show interactive effects in predicting remission to antidepressant treatmentHippocampal N-acetylaspartate concentration and response to riluzole in generalized anxiety disorder.Novel drugs and therapeutic targets for severe mood disorders.Treatment of generalized anxiety disorder: a comprehensive review of the literature for psychopharmacologic alternatives to newer antidepressants and benzodiazepines.Novel glutamatergic agents for major depressive disorder and bipolar disorder.Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: a pilot randomized placebo-controlled trial.Atypical antipsychotics in primary generalized anxiety disorder or comorbid with mood disorders.A pilot study of hippocampal volume and N-acetylaspartate (NAA) as response biomarkers in riluzole-treated patients with GAD.Riluzole effect on occipital cortex: a structural and spectroscopy pilot study.Biologic Commonalities between Mental Illness and Addiction.Modulation of stress consequences by hippocampal monoaminergic, glutamatergic and nitrergic neurotransmitter systems.Delayed amnesic syndrome after riluzole use in major depressive disorder: a case report.Riluzole in psychiatry: a systematic review of the literature.Acute shift in glutamate concentrations following experimentally induced panic with cholecystokinin tetrapeptide--a 3T-MRS study in healthy subjectsPreliminary evidence of riluzole efficacy in antidepressant-treated patients with residual depressive symptoms.The role of the tripartite glutamatergic synapse in the pathophysiology and therapeutics of mood disorders.Advances in pharmacotherapy for pediatric anxiety disorders.New approaches to the pharmacological management of generalized anxiety disorder.Glutamate-based anxiolytic ligands in clinical trials.Novel pharmacological agents targeting memory and cognition in the treatment of anxiety disorders.Treatment of pediatric anxiety disorders.Glutamate dysregulation and glutamatergic therapeutics for PTSD: Evidence from human studies.A double-blind, placebo controlled, randomized trial of riluzole as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia.Involvement of NMDA receptor complex in the anxiolytic-like effects of chlordiazepoxide in miceA Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Comparison Design Trial of Adjunctive Riluzole for Treatment-Resistant Major Depressive Disorder.Inflammatory Mediators in Mood Disorders: Therapeutic Opportunities.Riluzole in the prelimbic medial prefrontal cortex attenuates veratrine-induced anxiety-like behaviors in mice.Patterns of anterior versus posterior white matter fractional anistotropy concordance in adult nonhuman primates: Effects of early life stress.(18)F-Labeling of Aryl-SCF3, -OCF3 and -OCHF2 with [(18)F]Fluoride.Synthesis and biological evaluation of new 2-amino-6-(trifluoromethoxy)benzoxazole derivatives, analogues of riluzole
P2860
Q24629266-6732D4E3-FF45-42D6-B04C-E42B1A3A616BQ24633004-C4E4ACB3-968D-4BBD-AAE9-94A5A3441096Q26770756-C997021F-A646-4E66-AC38-271C0AB9770AQ30437449-9D040768-90BB-40E9-8A79-C502DE040D47Q30457479-172E7D92-D988-4657-8689-B85A701361D8Q33598320-73EF1AAA-8C04-4874-B2A2-CA282BAEECB3Q34183517-2437227A-E88C-482B-9941-0826BD979BE1Q34661625-684D5869-0E96-418F-BB92-4DDCE0A62FACQ34716110-9E092A61-0181-4A21-A373-C9632B6DD01FQ34732759-0B0D5423-5EF7-4271-8537-1941ED6D9B73Q35252034-F677FEFC-A8A2-4454-8078-5DE3193C74F7Q35661119-0455F1F5-8A91-4567-B96B-9A2BF641C185Q36029739-65E7C290-B480-4197-A8AD-107AA92ED6E9Q36205791-300442BF-787B-467D-9265-6E34EC1CF74DQ36323051-B9271046-4734-4061-B1E2-C484674D49CDQ36374329-543DFE3C-31A7-4434-A18C-CF14350CE1A5Q36756858-0A21D363-BA05-4FF2-895C-6FAF8FA4EA1FQ36871849-AD0CFD5F-BB18-4F63-B890-B5C48141B601Q36927081-798FCE35-2DA6-4865-AAEC-E866586BE433Q36983354-18DCAC9C-00EF-4654-88DC-DECF5502E9FBQ37030195-23C15B3E-7FD8-4C86-BD97-F148CCB5035DQ37368290-51A5A0FF-9390-4A5D-84A5-54D0B3870F4AQ37387700-C49536DA-F704-43CD-983A-0A1EEDDA6AD2Q37827822-2B9B1824-2861-42B3-9278-DB5CABC3A93CQ38071131-4DFAB592-6288-415B-9DDE-6FB8C06B14F9Q38110306-B7B29F7A-C6B9-436A-A282-F7CA31E80B91Q38137924-B0363AC7-8B1D-4641-8F5E-5D4A2CAE5E5CQ38166460-9D76C66C-9EF4-47FF-BDB5-807E0F55F588Q38787388-A62B6DCA-F8DD-4D7B-B79B-2E6498B85932Q39220948-76F49A1F-524E-4800-928E-880C249FD230Q42019741-7F277BBD-CCC3-4197-9C21-CD81D17393AAQ47710967-E38F2C99-2C68-4510-B599-813E3D386F2BQ47745353-9C9F2BB2-7F21-47B5-A0FE-2FFAA6492630Q47830712-A4A4BFF3-F13B-4460-8E22-9FD308D91F9EQ49044515-AE1BA65B-BEAC-4985-9CB0-5D84877E7FDBQ53441762-1F2E4273-BAD7-4006-9CC8-44499EB2965BQ58862064-5A000CF7-5846-48D6-B64E-7C2D38C38DB4
P2860
Open-label trial of riluzole in generalized anxiety disorder.
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Open-label trial of riluzole in generalized anxiety disorder.
@ast
Open-label trial of riluzole in generalized anxiety disorder.
@en
Open-label trial of riluzole in generalized anxiety disorder.
@nl
type
label
Open-label trial of riluzole in generalized anxiety disorder.
@ast
Open-label trial of riluzole in generalized anxiety disorder.
@en
Open-label trial of riluzole in generalized anxiety disorder.
@nl
prefLabel
Open-label trial of riluzole in generalized anxiety disorder.
@ast
Open-label trial of riluzole in generalized anxiety disorder.
@en
Open-label trial of riluzole in generalized anxiety disorder.
@nl
P2093
P1476
Open-label trial of riluzole in generalized anxiety disorder.
@en
P2093
Harold A Sackeim
Heidi A Fitterling
Jack M Gorman
Jeremy D Coplan
Jonathan M Amiel
Sanjay J Mathew
P304
P356
10.1176/APPI.AJP.162.12.2379
P407
P577
2005-12-01T00:00:00Z